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Background: Soybeans are one of causative foods for infantile onset allergies in Japan. This study aimed to
analyze the results of soybean challenge tests that were conducted over approximately 7 years at our insti-
tution. Using the test data, we sought to identify the responses and clinical proﬁles of patients with soybean
allergies, and to investigate the relationship between the responses and soybean sensitization status.
Methods: Between July 2004 and May 2010, 142 cases (125 patients) underwent food challenge tests
(100 g of silken tofu) for the diagnosis of soybean allergy or conﬁrmation of their tolerance. The patients'
characteristics, soybean sensitization status, and responses to the challenge tests were retrospectively
evaluated.
Results: Among the subjects who underwent the soybean challenge test, the male/female ratio was 1.6
(87/55), and the mean age at the test was 2.8 ± 1.7 years. The positive rate for the challenge test was
38.7%. Induced symptoms were observed in the skin (81.8%), respiratory system (50.9%), and gastroin-
testinal system/mucosal membrane/anaphylaxis (12.7%). Intramuscular epinephrine was administered to
all 7 patients who experienced an anaphylactic reaction. The sensitivity, speciﬁcity, positive predictive
value, negative predictive value, and diagnostic efﬁciency of soybean-speciﬁc IgE titers were low for
predicting the responses to the challenge test.
Conclusions: Soybean allergies were diagnosed in only 18% of the subjects with positive sensitization to
soybeans. Therefore, soybean-speciﬁc IgE titers are not an effective predictor of a positive response to the
challenge test.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In Japan, soybeans are often ingested in the form of tofu, and this
food is used for weaning during early infancy. Therefore, soybean
allergies often occur in the form of infant atopic dermatitis that is
caused by food allergies or as immediate-type reactions and oral
allergy symptoms after early childhood. Based on a report by Ito
et al.,1 soybeans are the fourth most common food in Japan that is
responsible for infant atopic dermatitis (AD) due to food allergies
(FA) (after eggs, milk, and wheat). Furthermore, according to a
national Japanese survey, soybeans are the 11thmost common foodr Allergy and Rheumatology,
i-ku, Sagamihara, Kanagawa
(M. Ebisawa).
ety of Allergology.
rgology. Production and hosting by Elsethat is responsible for immediate-type food allergies.2 Moreover,
many children who are sensitized to soybeans can unintentionally
ingest soybeans. Therefore, we retrospectively analyzed the re-
sponses to a soybean challenge test (that was performed using tofu)
among patients who underwent the test at our institution.
Methods
Patients
This retrospective study evaluated children who presented to
the Department of Pediatrics, Sagamihara National Hospital
(Kanagawa, Japan), between July 2004 and May 2010, and were
tested for food-speciﬁc IgE titers and/or underwent the skin prick
test (SPT), due to suspicion of any food allergy. Among these pa-
tients, we found 1710 children who were positive for soybean
sensitization (Fig. 1). Among these children, 1403 cases werevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. Soybean allergy among sensitized participants at Sagamihara National Hospital between 2004 and 2010. Sensitization to soybeanwas deﬁned as a titration result positive for
soybean-speciﬁc IgE antibody or a skin prick test result positive for soybean. Soybean allergy was deﬁned as a positive result in a soybean challenge test or convincing immediate
reaction to soybean. OFC, Oral food challenge.
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ingesting soybeans and were diagnosed as not having a soybean
allergy. Among the remaining 307 children, 177 children exhibited
clear immediate-type reactions after unknowingly ingesting soy-
beans, and were excluded. Therefore, a soybean challenge test was
administered to the remaining 130 children. However, we subse-
quently excluded 19 children because they had undergone an oral
food challenge test at another hospital or clinic. Furthermore, we
included 14 children who were referred to our department from
other hospitals and underwent the soybean challenge test with no
history of sensitization. Therefore, this study included a total of 125
children (mean age at testing, 2.8 ± 2.7 years). Among these chil-
dren, 13 children underwent the challenge test twice, 4 underwent
the soybean challenge test 3 times, and no patients underwent the
test 4 times. Therefore, the results of the soybean challenge test
were investigated in 142 cases (87 boys, 55 girls).
All patients and/or their guardians provided their informed
consent before the testing, and all tests were performed in the
presence of the guardian and a physician. This study's design was
reviewed and approved by the ethics committee of Sagamihara
National Hospital.Candidates for the food challenge test
The food challenge tests were conducted for two purposes: to
deﬁnitively diagnose a soybean allergy (after food elimination
testing, n ¼ 82 cases) and to determine tolerance after food elim-
ination had been initiated (based on a prior diagnosis, n¼ 60 cases).
The challenge test to determine tolerance was conducted when >1
year had passed since the last symptom episode (due to accidental
ingestion) or when a challenge test was requested by the guardian,
due to an observed declining trend in the soybean-speciﬁc IgE
levels during the elimination period.Oral soybean challenge test
The challenge tests were conducted under the assumption that
soybean ingestion was avoided for >2 weeks, that no anti-allergic
drugs (e.g., antihistamines or other anti-allergic drugs) had been
administered within the last 48 h, and that the patient's health
status was suitable for determining symptoms. Candidates for the
challenge test in the outpatient department were patients whose
soybean-speciﬁc IgE antibody titers were was less than class 2 andwho had no history of an immediate-type reaction. All other pa-
tients underwent the challenge test in the inpatient department.
Two different challenge test protocols were used during the
study period (Fig. 2). For the ﬁrst protocol, 100 g of silken tofu (4.9 g
of soybean protein) was divided into 5 unequal pieces, which were
given to children at 15-min intervals for 1 h. However, since January
2009, we have used a revised protocol whereby the tofu is divided
into 3 unequal pieces, which are given to children at 0 min, 30 min,
and 1 h. We have previously compared the results for these two
tests, and found that no signiﬁcant differences were observed in the
test results (unpublished data). All symptoms were evaluated using
a scoring sheet that was based on the Symptom Scoring System,
which is a reorganized version of the American Academy of Allergy,
Asthma, and Immunology's Challenge Test Manual.3 Children were
followed for 24 h after the challenge test in the inpatient depart-
ment, and for 3 h after the challenge test in the outpatient
department. Open challenges are routine at our clinic for very
young children, and follow the practices that are recommended by
the European Academy of Allergology and Clinical Immunology.4
Immunology testing
Hematological tests (total serum and soybean-speciﬁc antibody
titers) were conducted within the 6 months before the challenge
test. All patients' IgE antibody titers were measured using the CAP-
FEIA immunoassay (Phadia, Uppsala, Sweden), and the SPT was
administered alongside the challenge test in some cases, using
drop-by-drop administration (2-cm intervals) of a soybean antigen
solution (Torii scratch extract; Torii Pharmaceutical). Next, the drop
sites were pressured using a bifurcated needle (Allergy Laboratories
of Ohio; USA) that was oriented perpendicular to the skin, and the
reaction was evaluated after approximately 15 min. Finally, a con-
trol solution (Torii Pharmaceutical) was used as a negative control.
The criteria for a positive SPT result included a response that was
>2-fold greater than the response for the negative control, with a
wheal measuring >2 mm in diameter, or an erythema measuring
>5 mm in diameter.5
In addition, the following parameters were extracted from the
patients' medical records for analysis:
1. Patient characteristics
We investigated the male/female ratio of the patients, the age at
which the challenge test was administered, the reason for
Fig. 2. Cumulative doses of soybean at oral food challenge. There are 2 methods of soybean challenge at our hospital. In the old method, 100 g of silken tofu (4.9 g of soybean
protein) was divided into 5 unequal pieces, which were given to children at 15-min intervals for 1 h. The current method uses a revised protocol in which the silken tofu is divided
into 3 unequal pieces, which are given to children at 0 min, 30 min, and 1 h. The total cumulative dose is 100 g of silken tofu. * This means doctors check for the presence or absence
of fever, rash, coughing, wheezing, abdominal pain, or diarrhea.
M. Sato et al. / Allergology International 65 (2016) 68e7370beginning soybean elimination, the age (months) at which elimi-
nation was initiated, and the rate of complications due to other
allergic diseases.
2. The predictive value of soybean-speciﬁc IgE antibody titers
We investigated the sensitivity, speciﬁcity, positive predictive
value, negative predictive value, and diagnostic efﬁciency for using
IgE titer classes 2 and 3 as the cut-off values.
3. Relationship between the challenge test response and
soybean-speciﬁc IgE antibody titers
After dichotomizing the soybean-speciﬁc IgE antibody titers (as
described above), we calculated and compared the number of cases
that underwent challenge testing, the number of positive cases
after the challenge tests, and the number of cases with anaphylactic
reactions.
4. Symptoms and treatments
We calculated the threshold positive value for the cases with
positive challenge test results. Next, we compared the symptoms in
each organ and their frequencies. Furthermore, we compared the
dispositions of the patients with positive challenge test results and
the frequencies of their symptoms.
Statistical analysis
All results were presented as mean ± standard deviation or
number (%). For the statistical analyses, Student's t-test was used to
compare continuous variables, and the c2 test was used to compare
categorical variables. Differences with a p-value of <0.05 were
considered statistically signiﬁcant. GraphPad Prism software(version 5, GraphPad Software, CA, USA) was used for all statistical
analyses.
Results
Patient characteristics
In this study, the male/female ratio was 1.6, and the mean pa-
tient age at the time of testing was 2.8 ± 1.7 years (range, 10
monthse9 years) (Table 1). The most common age group was 1e2
years old, and 8 childrenwere <1-year-old. Elimination of soybeans
was most commonly initiated because of positive sensitization to
soybeans without ingestion of soybeans (55/125, 44%), followed by
immediate-type reactions (46/125, 36.8%), positive elimination test
results (19/125, 15.2%), and other reasons (guardian's discretion; 5/
125, 4%). Soybean elimination was initiated at a mean age of
8.9 ± 9.4 months. The most common complications due to other
allergic diseases (except FAs) were AD (81.6%), followed by bron-
chial asthma (BA, 17.6%), allergic rhinitis (14.4%), and allergic
conjunctivitis (10.4%).
The responses to the soybean challenge test indicated that 55
cases (38.7%) were positive and 87 cases (61.3%) were negative for
soybean allergies. The mean age at the challenge tests was 3.1 ± 1.6
years in the positive group and 2.6 ± 1.8 years in the negative group,
and this difference was statistically signiﬁcant (p < 0.05). A com-
parison of the challenge test responses revealed that the positive
group had signiﬁcantly higher total serum and soybean-speciﬁc IgE
titers before the challenge test, and a signiﬁcantly wider SPT wheal
diameter, compared to the negative group (all, p < 0.01).
The predictive value of soybean-speciﬁc IgE antibody titers
When we used class 2 soybean-speciﬁc IgE titers as the cut-off
value, the test had a sensitivity of 30.9%, a speciﬁcity of 43.7%, a
Table 1
Comparison of patient characteristics in the positive and negative response groups.
Results of the soybean challenges Total Positive (n ¼ 55) Negative (n ¼ 87) P-value
Sex (male/female) 1.6 (87/55) 1.6 1.6 n.s.
Average age at challenge (years) 2.8 ± 1.7 3.1 ± 1.6 2.6 ± 1.8 <0.05
Avoiding soybean due to immediate reactions (%) 36.6 41.8 32.2 n.s.
History of soybean-induced anaphylaxis (%) 8.5 12.7 5.7 n.s.
Average age at initiation of soybean avoidance (m) 8.9 ± 9.4 7.6 ± 3.1 10.0 ± 11.9 n.s.
Complications AD (%) 81.6 83.6 81.6 n.s.
BA (%) 17.6 18.2 17.2 n.s.
Serum total IgE (IU/mL) 1350.5 ± 2467.0 2078. ± 3491.6 890.4 ± 1330.8 <0.05
Soybean speciﬁc IgE (IU/mL) 11.3 ± 19.0 20.4 ± 26.8 5.6 ± 7.4 <0.01
SPT (wheal) (mm) 5.1 ± 4.4 6.5 ± 4.5 (n ¼ 45) 3.9 ± 4.2 (n ¼ 54) <0.01
Other food allergies 116 38 78 n.s.
Data are presented as mean ± standard deviation. Differences were evaluated using the unpaired t-test or c2 test, as appropriate.
SPT, skin prick test; AD, atopic dermatitis; BA, bronchial asthma; n.s., not signiﬁcant.
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50.0%, and a diagnostic efﬁciency of 30.7% (Table 2). When class 3
was used as the cut-off value, the test had a sensitivity of 67.3%, a
speciﬁcity of 6.9%, a positive predictive value of 31.4%, a negative
predictive value of 25.0%, and a diagnostic efﬁciency of 30.3%.
Relationship between the challenge test response and soybean-
speciﬁc IgE antibody titers
The challenge test was conductedmost commonly for IgE class 3
(Fig. 3). At class 5 or higher, all cases were positive in the challenge
test, and two positive cases were observed for class 0. At class 2 or
below, none of the patients had experienced anaphylaxis.
Positive symptoms and their treatment
Investigation of the 55 positive cases revealed that the mean
threshold value for positivity was 57.2 ± 41.3 g. The most common
symptoms were skin symptoms (45 cases, 81.8%), followed by
respiratory symptoms (28 cases, 50.9%) and gastrointestinal/
mucosal membrane/anaphylaxis (each: 7 cases, 12.7%) (Fig. 4a).
Treatment of these symptoms was administered as oral or intra-
venous antihistamines (33 cases, 55.9%) or steroids (23 cases, 39%)
(Fig. 4b). A bronchodilator was administered via an inhaler for 16
cases (27.1%) with respiratory symptoms. Epinephrine was injected
intramuscularly in all 7 cases that experienced anaphylaxis.
Discussion
In this study, we investigated and summarized the responses to
soybean challenge tests that were conducted at a single Japanese
institution. Furthermore, this study examined a large population of
children (of various ages), including cases of FA that were compli-
cated with infant AD and cases with a history of immediate-type
reactions. However, we conﬁrmed soybean allergies in only 307
of 1710 children (18%) who had previous sensitization to soybeans.
Similarly, Ostblom et al. have reported that symptoms appeared in
only 7 of 68 (10%) soybean-sensitized children who were 4-year-
old.6 Furthermore, Ikematsu et al. have evaluated soybean-speciﬁcTable 2
Diagnostic value of soybean-speciﬁc IgE in 142 cases.
Time Sensitivity
(%)
Speciﬁcity
(%)
Positive
predictive
value (%)
Negative
predictive
value (%)
Diagnosis
efﬁciency (%)
Class 2 30.9 43.7 25.8 50 30.7
Class 3 67.3 6.9 31.4 25 30.3IgE titers in cases of complicated FA among 106 infants with AD.
Although they reported that 21 of 106 cases (19.8%) were positive,
only 11 cases (7.4%) were ultimately diagnosed with soybean al-
lergies, using a food elimination challenge test.7 Therefore, diag-
nosing a soybean allergy based only on positive sensitization to
soybean could lead to the unnecessary elimination of various foods.
According to a national investigation of 39 Japanese institutions,
the positive rate was 22% for a challenge test that used dried soy-
bean powder (equivalent to 20 g of soybean protein of silken tofu
conversion) that was developed by the Kewpie Food Research
Institute.8 Jarvinen et al. have reported that 40 of 138 cases (29%)
were positive for a soybean challenge test among patients who
were 18-year-old.9 On the other hand, the positive rate in the
present study was 38.7%, which is higher than the previously re-
ported positive rates. Many factors that affect the results of food
challenge tests have been reported. These differences might have
been affected by differences in patients' background and challenge
food.
Komata et al. have reported that children with a positive chal-
lenge test result tended to have higher titers of food-speciﬁc IgE,Fig. 3. The relationship between soybean-speciﬁc IgE classes and responses to the
challenges (n ¼ 142 cases). The black bar represents “Negative”, the gray bar represents
“An (þ)”, the white bar represents “An ()”. “Negative’ means that the patients did not
have any allergic symptoms and “positive” means that the patients had allergic
symptoms in the soybean food challenge. In addition, among the patients with positive
results, those who had anaphylactic shock were described as An (þ) and those who
had no anaphylactic shock were described as An (). IgE antibody titers were
measured by using ImmunoCAP (Phadia, Uppsala, Sweden).”
Fig. 4. Allergic reactions in the soybean food challenge and their treatment.
(a) Allergic reactions that were induced by the soybean challenges (55 positive cases).
(b) Treatment frequency for adverse reactions that were induced by the soybean
challenges (55 positive cases).
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increased risk of developing allergic symptomswas associated with
increases in their IgE titers.10 In the present study, we also found
that soybean-speciﬁc and total serum IgE titers were signiﬁcantly
higher in the positive group. However, previous reports have all
reported that soybean-speciﬁc IgE titers were not effective for
predicting soybean allergies. For example, Sampson et al.11 have
reported that the relationship between soybean challenge test re-
sults and soybean-speciﬁc IgE titers was minimal, based on their
retrospective analysis, and that no effective cut-off value could be
obtained via receiver operating characteristic curve analysis. In
addition, Sampson et al.12 have reported that the sensitivity, spec-
iﬁcity, positive predictive value, negative predictive value, and
diagnostic efﬁciency of soybean-speciﬁc IgE titers were low, based
on their prospective study of children who underwent challenge
tests because of soybean-speciﬁc IgE positivity. Moreover, Celik-
Bilgili et al.13 have reported low sensitivity, speciﬁcity, and posi-
tive predictive values in their study of the soybean challenge test.
Similarly, we found that the predictive values were all lowwhenwe
used soybean-speciﬁc IgE classes 2 and 3 as the cut-off values.
Therefore, although the risk of developing allergic symptoms in-
creases with higher soybean-speciﬁc IgE titers, the antibody titer
alone does not appear to be an effective predictor of positive
challenge test results.
Although 2 cases with class 0 soybean-speciﬁc IgE titers
exhibited positive challenge test results, none of the cases with
class 2 or lower titers experienced anaphylaxis. In contrast,
Ballmer-Weber et al. have reported cases with hypotension or
breathing difﬁculty, even at class 2 or lower titers.14 However, theirstudy used an amount of protein that was >10-fold greater than
that used in the present study, which may explain the discrepancy
in the distribution of cases with severe symptoms. Component
resolved diagnosis is a new concept in the investigation of pediatric
allergic disease. In recent years, soy components have been eluci-
dated. We found these to be useful in the diagnosis of soy
allergy.15e17
Komata et al.10 have reported that the most common type of
symptoms in the soybean challenge test involved the skin (98%),
which were followed by respiratory symptoms (24%), anaphylaxis,
and gastrointestinal symptoms (both 5%). Those ﬁndings are
consistent with the ﬁndings of the present study. However, in the
US, Savage et al.18 have reported that 68% of their cases involved
skin symptoms, while 37% of their cases involved gastrointestinal
symptoms. In addition, Sampson et al.11 have reported incidences of
66.7% for skin symptoms, 61.9% for gastrointestinal symptoms, and
23.8% for respiratory symptoms. Furthermore, Aaronov et al.19 have
reported incidences of 87% for gastrointestinal symptoms (the
highest reported incidence) and 4% for anaphylaxis, based on their
epidemiological study in Israel. In contrast, we observed a much
lower incidence of gastrointestinal symptoms, which may be
related to differences in the form of the soybeans that were used for
ingestion. Furthermore, analyses of food challenge-related symp-
toms at our institution have identiﬁed respiratory symptoms
(15.4%) and anaphylaxis (0%) for hen's egg,20 as well as respiratory
symptoms (64.9%) and anaphylaxis (8.1%) for milk.21 Therefore, our
ﬁndings indicate that soybeans are more likely to cause respiratory
symptoms and anaphylaxis, compared to other challenge foods.
As our soybean challenge test was more likely to cause
anaphylaxis (compared to other challenge tests), the soybean
challenge test should be conducted under close monitoring, with
immediate and appropriate treatment if necessary.
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